Acrx stock forecast.
Nabriva Therapeutics plc (NASDAQ:NBRV) announced its quarterly earnings data on Thursday, May, 6th. The biotechnology company reported ($13.25) EPS for the quarter, beating analysts' consensus estimates of ($16.75) by $3.50. The biotechnology company earned $2.53 million during the quarter, compared to analysts' expectations of …
The Best Biotech Stocks of November 2023. Stock (ticker) 5-Year Average Annual EPS Forecast. Amylyx Pharmaceuticals, Inc. (AMLX) 65.0%. Biomarin Pharmaceutical (BMRN) 58.0%. Exelixis, Inc. (EXEL)Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Marker Therapeutics Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The ...Stable Share Price: ACRX is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 13% a week. Volatility Over Time : ACRX's weekly …Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Marker Therapeutics Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The ...
ACRX has an Altman Z-Score of -27.53 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for AcelRx Pharmaceuticals, Inc. (ACRX) stock, including valuation metrics, financial numbers, share information and more.ACRX stock had an impressive performance on October 20, 2023, with the potential for significant growth in the future. According to data from CNN Money, two analysts offering 12-month price forecasts for AcelRx Pharmaceuticals Inc have a median target of 4.63, with a high estimate of 5.00 and a low estimate of 4.25.Nov 29, 2023 · The AcelRx Pharmaceuticals stock price gained 3.66% on the last trading day (Wednesday, 15th Nov 2023), rising from $0.464 to $0.481. During the last trading day the stock fluctuated 11.04% from a day low at $0.450 to a day high of $0.500. The price has fallen in 6 of the last 10 days and is down by -9.09% for this period.
AcelRx Pharmaceuticals (ACRX) came out with a quarterly loss of $1 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $1.20 per share a year ago. These ...Which healthcare penny stocks should the risk-tolerant crowd have on their radar right now? AcelRx Pharmaceuticals ( ACRX 3.95%) and Sundial Growers ( SNDL 4.89%) are two potential diamonds in the ...
A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 ...Stock Price Forecast. The 2 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 6.65, with a high estimate of 9.50 and a low estimate of 3.80. The ...Get the latest AcelRx Pharmaceuticals Inc (ACRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. May 9, 2023 · ACRX competes with other companies such as ATXI, PTIX, and PBLA. On May 9, 2023, ATXI stock remained unchanged, while PTIX stock increased by 2.06%. In contrast, PBLA stock decreased by 21.71%. ACRX is set to report its next earnings on May 11, 2023. ACRX operates in the health technology sector and is involved in the major pharmaceuticals ... Acelrx Pharmaceuticals Stock Chart and Share Price Forecast, Short-Term "ACRX" Stock Prediction for Next Days and Weeks Walletinvestor.com Acelrx Pharmaceuticals Inc (ACRX) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024
AcelRx Pharmaceuticals, Inc. Common Stock (ACRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
ACRX Business Overview. ACRX is a pharmaceutical company operating in the space of supervised medical settings, i.e. hospitals, ASCs (Ambulatory Surgical Centers), and procedural suites, such as ...
Acurx Pharmaceuticals, Inc. Analyst Report: Pfizer Inc. Pfizer is a leading developer and manufacturer of pharmaceuticals and biotech drugs. Its products include oncology and immunology drugs ...12 Wall Street analysts have issued 1-year price targets for Arcellx's stock. Their ACLX share price targets range from $39.00 to $104.00. On average, they predict the company's stock price to reach $54.77 in the next twelve months. This suggests a possible upside of 2.8% from the stock's current price.Based on 7 Wall Street analysts offering 12 month price targets for Applied Digital Corporation in the last 3 months. The average price target is $15.25 with a high forecast of $19.00 and a low forecast of $12.00.The average price target represents a 240.40% change from the last price of $4.48.AcelRx Pharmaceuticals ( NASDAQ: ACRX) is scheduled to announce Q1 earnings results on Wednesday, May 10th, after market close. The consensus EPS Estimate is -$0.80 and the consensus Revenue ...Stock Price Forecast. The 5 analysts offering 12-month price forecasts for BioXcel Therapeutics Inc have a median target of 11.00, with a high estimate of 18.00 and a low estimate of 4.00. The ...Based on 4 Wall Street analysts offering 12 month price targets for Tempest Therapeutics in the last 3 months. The average price target is $21.67 with a high forecast of $47.00 and a low forecast of $8.00. The average price target represents a 452.81% change from the last price of $3.92. Highest Price Target $47.00. Average Price Target $21.67.AcelRx Pharmaceuticals, Inc. 05 Apr, 2023, 08:30 ET. In connection with closing, AcelRx received approximately $2.7 million from Alora Pharmaceuticals and Aguettant. AcelRx announces full ...
Acelrx Pharmaceuticals Stock Forecast, "ACRX" Share Price Prediction Charts Is "Acelrx Pharmaceuticals Inc" a Good Investment? Current price today: 0.640 USD (+4.015%) …Stock Price Forecast. The 2 analysts offering 12-month price forecasts for AcelRx Pharmaceuticals Inc have a median target of 4.63, with a high estimate of 5.00 and a low estimate of 4.25. The median estimate represents a +617.05% increase from the last price of 0.65. Iterum Therapeutics plc (NASDAQ:ITRM) released its quarterly earnings results on Friday, November, 12th. The company reported $0.30 EPS for the quarter, missing the consensus estimate of $1.80 by $1.50. During the same period last year, the company earned ($5.10) EPS. View the latest news, buy/sell ratings, SEC filings and insider transactions ...AcelRx Pharmaceuticals (NASDAQ:ACRX) dropped ~15% aftermarket as the firm will effect a 1-for-20 reverse stock split on Tuesday at 5.01 pm ET.The company's stock will begin trading on a split ...JaysonPhotography. HC Wainwright upgraded AcelRx ( NASDAQ: ACRX) to buy from neutral citing the likely Emergency Use Authorization approval of Niyad (nafamostat) as an anticoagulant into the ...Nov 17, 2014 · Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Corbus Pharmaceuticals Holdings Inc have a median target of 20.00, with a high estimate of 20.00 and a low estimate of 20.00. Stock Price Forecast. The 2 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 6.65, with a high estimate of 9.50 and a low estimate of 3.80. The ...
Cash Ratio forecast for AcelRx Pharmaceuticals (ACRX) stock. Annual Cash Ratio forecast for AcelRx Pharmaceuticals stock for 2021 is 1.08299256789893. It is increase 0.39% from the last annual Cash Ratio report of 1.07883329659834. Annual Cash Ratio forecast for 2022 is 1.07667132533243, and 2023 is 1.07669258943835.According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.
Find real-time INPX - Inpixon stock quotes, company profile, news and forecasts from CNN Business.Find real-time OTLK - Outlook Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.Acelrx (ACRX) has received a new Buy rating, initiated by H.C. Wainwright analyst, Ed Arce. Ed Arce has given his Buy rating due to several key ...The average twelve-month price prediction for AcelRx Pharmaceuticals is $4.63 with a high price target of $5.00 and a low price target of $4.25. Learn more on ACRX's analyst rating history. Do Wall Street analysts like AcelRx Pharmaceuticals more than its competitors? Analysts like AcelRx Pharmaceuticals more than other Medical companies.People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.ACRX Stock Analysis Overview What this means: InvestorsObserver gives Acelrx Pharmaceutica (ACRX) an overall rank of 35, which is below average. Acelrx …
AcelRx Pharmaceuticals, Inc. Common Stock (ACRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
5. Next. From AI system, total return is 2366.52% from 4098 forecasts. See more long term and short term forecasts for your favorite stock.
Iterum Therapeutics plc (NASDAQ:ITRM) released its quarterly earnings results on Friday, November, 12th. The company reported $0.30 EPS for the quarter, missing the consensus estimate of $1.80 by $1.50. During the same period last year, the company earned ($5.10) EPS. View the latest news, buy/sell ratings, SEC filings and …ACRX Stock Forecast. While there’s much to be desired from the market after this year, analysts remain bullish. Most recently, Cantor Fitzgerald adjusted its rating to $4 but maintained an Overweight rating. Based on current trading levels, that target sits 615% higher right now.ACRX stock forecast Our latest prediction for Acelrx Pharmaceuticals Inc's stock price was made on the Sept. 14, 2023 when the stock price was at 0.88$ . In the short term (2weeks), ACRX's stock price should underperform the market by -3.79% .Based on 4 Wall Street analysts offering 12 month price targets for Tempest Therapeutics in the last 3 months. The average price target is $21.67 with a high forecast of $47.00 and a low forecast of $8.00. The average price target represents a 452.81% change from the last price of $3.92. Highest Price Target $47.00. Average Price Target $21.67.AcelRx Pharmaceuticals, Inc. Common Stock (ACRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Nabriva Therapeutics plc (NASDAQ:NBRV) announced its quarterly earnings data on Thursday, May, 6th. The biotechnology company reported ($13.25) EPS for the quarter, beating analysts' consensus estimates of ($16.75) by $3.50. The biotechnology company earned $2.53 million during the quarter, compared to analysts' expectations of …Nov 3, 2021 · Cash Ratio forecast for AcelRx Pharmaceuticals (ACRX) stock. Annual Cash Ratio forecast for AcelRx Pharmaceuticals stock for 2021 is 1.08299256789893. It is increase 0.39% from the last annual Cash Ratio report of 1.07883329659834. Annual Cash Ratio forecast for 2022 is 1.07667132533243, and 2023 is 1.07669258943835. AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. AcelRx's lead product candidate, Niyad is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption, or IDE ...Stock Price Forecast The 6 analysts offering 12-month price forecasts for CytomX Therapeutics Inc have a median target of 2.13, with a high estimate of 3.50 and a low estimate of 2.00.
A stock with insider buying, one presenting data next year, and a total dog walk into a bar... I'll keep it short and sweet. New article on KPLT LPTX…Which healthcare penny stocks should the risk-tolerant crowd have on their radar right now? AcelRx Pharmaceuticals ( ACRX 3.95%) and Sundial Growers ( SNDL 4.89%) are two potential diamonds in the ...AcelRx Pharmaceuticals Inc. 0.6199. Delayed Data. As of Nov 21. +0.1189 / +23.73%. Today’s Change. 0.43. Today ||| 52-Week Range. 2.78. Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Instagram:https://instagram. crypto exchange with debit cardnew crypto on coinbasebest brokers for bondslly stock forecast Track Acelrx Pharmaceuticals Inc (ACRX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors nickel worth 1964personal loan for senior citizens If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets. home warranty water damage Stock Price Forecast The 6 analysts offering 12-month price forecasts for CytomX Therapeutics Inc have a median target of 2.13, with a high estimate of 3.50 and a low estimate of 2.00.Sep 26, 2023 · On September 26, 2023, an intriguing block trade took place involving ACRX, a security with a trading price of $0.55. Acasti Pharma Inc. (ACST) share price prediction for 2023, 2024, 2025, 2026 and 2027. ACST one year forecast. Acasti Pharma stock monthly and weekly forecasts.